Amarantus BioSciences, Inc. to Present at 6th Annual Livingston Securities Life Science Stakeholders Summit

SUNNYVALE, Calif., Oct. 16, 2013 (GLOBE NEWSWIRE) -- Amarantus Bioscience Holdings, Inc. (OTCQB:AMBS), a biotechnology company focused on the discovery and development of novel diagnostics and therapeutics related to neurodegeneration and apoptosis, today announced that President & CEO Gerald E. Commissiong will present at the 6th annual Livingston Securities Life Science Stakeholders Summit on Thursday, October 17th, 2013. The conference will be held at the offices of Akerman Senterfitt, located at 666 5th Ave in midtown Manhattan.

Help employers find you! Check out all the jobs and post your resume.